Identification and Clinical Translation of Biomarker Signatures: Statistical Considerations-Reference-Cited by-同舟云学术

Identification and Clinical Translation of Biomarker Signatures: Statistical Considerations

Published:2016-11-29 Issue: Volume: Page:103-114
ISSN:1064-3745
Container-title:Multiplex Biomarker Techniques
language:
Short-container-title:

Author:

Schwarz Emanuel

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-6730-8_6

Reference44 articles.

1. Cohen Freue GV, Meredith A, Smith D, Bergman A, Sasaki M, Lam KK et al (2013) Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation. PLoS Comput Biol 9:e1002963

2. Zhang Z, Chan DW (2010) The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomarkers Prev 19:2995–2999

3. Alymani NA, Smith MD, Williams DJ, Petty RD (2010) Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation. Eur J Cancer 46:869–879

4. Deyati A, Younesi E, Hofmann-Apitius M, Novac N (2013) Challenges and opportunities for oncology biomarker discovery. Drug Discov Today 18:614–624

5. Jin G, Zhou X, Wang H, Wong STC (2010) The challenges in blood proteomic biomarker discovery. In: Pham T (ed) Comput Biol. Springer, New York, pp 273–299

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method;Expert Review of Anticancer Therapy;2021-02-10

2. Automation to optimise physician treatment of individual patients: examples in psychiatry;The Lancet Psychiatry;2019-04

3. Point-of-Care Testing and Personalized Medicine for Metabolic Disorders;Methods in Molecular Biology;2018